CORECEPTOR MODIFICATION OF TCR TYROSINE KINASE SIGNALS
TCR 酪氨酸激酶信号的辅助受体修饰
基本信息
- 批准号:6376122
- 负责人:
- 金额:$ 24.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-12-08 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Adapted from applicant's abstract) T cell receptor (TCR) antigen
recognition induces the formation and stabilization of a specialized
"immunological synapse" at the T cell: antigen presenting cell (APC) junction.
This junction is generated by the recruitment and exclusion of particular
proteins from the contact area and is required for T cell activation. Advances
in cell biology have revealed that the plasma membrane is composed of laterally
associated "lipid rafts" which float in a sea of otherwise glycerophospholipid
rich membrane. Lipid rafts are enriched in a subset of cellular proteins and
have been implicated in signal transduction, cytoskeletal reorganization and
protein sorting. We hypothesize that lipid raft/non-raft partitioning provides
the molecular basis for protein sorting which organizes the TCR and co
stimulators, signal transducers and the actin cytoskeleton at the T cell:APC
interface. Our recent studies discriminate two distinctly regulated
lipid-raft-dependent T cell activation steps: 1) the TCR engagement-induced
phosphorylation and concentration of TCR( and signal transducers within lipid
rafts and 2) the TCR/CD48 co stimulation and Lck-SH3-domain-dependent migration
of lipid rafts to the TCR contact cap. Whereas T cell activation (TCR induced
IL-2 production) requires both steps, T cell inactivation (TCR-induced
apoptosis) is unaffected by disruption of the second step. Therefore, we
hypothesize that the TCR/mediated-mediated recruitment of lipid rafts to the
TCR contact site facilitates the construction of a raft-based platform, which
modulates the functional outcome of TCR engagement. To test the role of
raft/non-raft membrane compartmentalization in organizing TCR signal
transduction and the actin cytoskeleton at the T cell:APC contact cap, we will
manipulate the raft/non raft partitioning of proteins involved in these
processes and determine the effects on T cell signals and activation (Aim 1).
To elucidate the molecular basis of TCR/co stimulation and the relationship
between raft reorganization and the functional outcome of TCR engagement we
will: a) characterize CD28, CD48 and LFA-1 costimulatory contributions to TCR
lipid raft reorganization and signal transduction events (Aim 2); b) explore
how subtle differences in TCR antigen binding properties affect antigen-induced
raft reorganization, signals and the functional outcome of TCR engagement (Aim
3) and; c) determine if T cells manipulate lipid raft composition and dynamics
throughout development to set thresholds for T cell activation (Aim 4). These
studies will lead to a better understanding of how TCR signals are regulated to
mediate distinct functional outcomes. Elucidation of lipid raft constituents
and the molecular mediators of raft reorganization will provide novel targets
for therapeutics aimed at independently modulating, individual TCR induced
responses such as : 1) inhibiting unwanted T cell activation responsible for
autoimmunity, graft rejection, and/or T cell transformation; 2) promoting
peripheral tolerance in allograft reactive and autoimmune T cells and 3)
potentiating tumor (or other) vaccines directed against sub optimally presented
antigens.
描述:(改编自申请者摘要)T细胞受体(TCR)抗原
认知诱导专业化的形成和稳定
T细胞:抗原提呈细胞(APC)交界处的“免疫突触”。
这一结点是由特定的招募和排除而产生的
来自接触区的蛋白质,是T细胞激活所必需的。预付款
在细胞生物学中已经揭示了质膜是由横向组成的
漂浮在甘油磷脂海洋中的相关“脂筏”
丰富的膜。脂筏富含一组细胞蛋白质,
与信号转导、细胞骨架重组和
蛋白质分类。我们假设脂筏/非脂筏的分配提供了
组织TCR和Co.的蛋白质分选的分子基础
刺激物、信号转导与T细胞的肌动蛋白细胞骨架
界面。我们最近的研究区分了两个明显受监管的
脂筏依赖的T细胞活化步骤:1)TCR参与诱导
TCR(和脂质内的信号转导)的磷酸化和浓度
RAFTS和2)TCR/CD48共刺激和LCK-SH3结构域依赖的迁移
将脂筏连接到TCR接触帽。而T细胞活化(TCR诱导
IL-2的产生)需要两个步骤,T细胞失活(TCR诱导
细胞凋亡)不受第二步中断的影响。因此,我们
假设TCR/介导的脂筏向血管内皮细胞募集
TCR联络地点为筏基平台的建造提供便利,该平台
调节TCR参与的功能结果。测试……的作用
组织TCR信号的RAFT/非RAFT膜分区
转导和T细胞上的肌动蛋白细胞骨架:APC接触帽,我们将
操纵与此相关的蛋白质的RAFT/非RAFT分配
处理并确定对T细胞信号和激活的影响(目标1)。
阐明TCR/co刺激的分子基础及其相互关系
在RAFT重组和TCR参与的功能结果之间
将:a)表征CD28、CD48和LFA-1对TCR的共刺激作用
脂筏重组和信号转导事件(目标2);b)探索
TCR抗原结合特性的细微差异如何影响抗原诱导
RAFT重组、信号和TCR接触的功能结果(AIM
3)和;c)确定T细胞是否操纵脂筏的组成和动力学
在整个发育过程中为T细胞激活设定阈值(目标4)。这些
研究将有助于更好地理解TCR信号是如何调节到
调节不同的功能结果。脂筏成分的研究进展
RAFT重组的分子介体将提供新的靶点
对于以独立调节为目的的治疗,个体TCR诱导
反应如下:1)抑制不想要的T细胞激活
自身免疫、移植排斥和/或T细胞转化;2)促进
同种异体反应性和自身免疫T细胞的外周免疫耐受
针对次优呈现的增强肿瘤(或其他)疫苗
抗原。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M CARRIE MICELI其他文献
M CARRIE MICELI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M CARRIE MICELI', 18)}}的其他基金
Identification of Enhancers of Therapeutic Exon Skipping for DMD
DMD 治疗性外显子跳跃增强子的鉴定
- 批准号:
7821508 - 财政年份:2009
- 资助金额:
$ 24.1万 - 项目类别:
Identification of Enhancers of Therapeutic Exon Skipping for DMD
DMD 治疗性外显子跳跃增强子的鉴定
- 批准号:
7938694 - 财政年份:2009
- 资助金额:
$ 24.1万 - 项目类别:
Galectin-1 regulation of T cell activation and tolerance
Galectin-1 对 T 细胞活化和耐受的调节
- 批准号:
6983416 - 财政年份:2003
- 资助金额:
$ 24.1万 - 项目类别:
Galectin-1 regulation of T cell activation and tolerance
Galectin-1 对 T 细胞活化和耐受的调节
- 批准号:
6755043 - 财政年份:2003
- 资助金额:
$ 24.1万 - 项目类别:
Galectin-1 regulation of T cell activation and tolerance
Galectin-1 对 T 细胞活化和耐受的调节
- 批准号:
6820004 - 财政年份:2003
- 资助金额:
$ 24.1万 - 项目类别:
Galectin-1 regulation of T cell activation and tolerance
Galectin-1 对 T 细胞活化和耐受的调节
- 批准号:
7148099 - 财政年份:2003
- 资助金额:
$ 24.1万 - 项目类别:
Galectin-1 regulation of T cell activation and tolerance
Galectin-1 对 T 细胞活化和耐受的调节
- 批准号:
6675798 - 财政年份:2003
- 资助金额:
$ 24.1万 - 项目类别:
CORECEPTOR MODIFICATION OF TCR TYROSINE KINASE SIGNALS
TCR 酪氨酸激酶信号的辅助受体修饰
- 批准号:
6512856 - 财政年份:1994
- 资助金额:
$ 24.1万 - 项目类别:
CORECEPTOR MODIFICATION OF TCR TYROSINE KINASE SIGNALS
TCR 酪氨酸激酶信号的辅助受体修饰
- 批准号:
2109176 - 财政年份:1994
- 资助金额:
$ 24.1万 - 项目类别:
相似海外基金
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
- 批准号:
DP240102905 - 财政年份:2024
- 资助金额:
$ 24.1万 - 项目类别:
Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23K28188 - 财政年份:2024
- 资助金额:
$ 24.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
- 批准号:
2339172 - 财政年份:2024
- 资助金额:
$ 24.1万 - 项目类别:
Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
- 批准号:
10577518 - 财政年份:2023
- 资助金额:
$ 24.1万 - 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23H03498 - 财政年份:2023
- 资助金额:
$ 24.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
- 批准号:
10676407 - 财政年份:2023
- 资助金额:
$ 24.1万 - 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
- 批准号:
22KK0277 - 财政年份:2023
- 资助金额:
$ 24.1万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
- 批准号:
10599584 - 财政年份:2023
- 资助金额:
$ 24.1万 - 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
$ 24.1万 - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10684172 - 财政年份:2022
- 资助金额:
$ 24.1万 - 项目类别:














{{item.name}}会员




